High-throughput Screening Market Expanding at a CAGR of 7.5% during 2024-2032

High-throughput Screening Industry Overview 2024-2032

Summary:

• The global high-throughput screening market size reached USD 25.2 Billion in 2023.
• The market is expected to reach USD 49.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032.
• Region-wise, the market has been classified into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
• Based on technology, the market has been segmented into ultra-high-throughput screening, cell-based assays, lab-on-a-chip, and label-free technology.
• On the basis of the products and services, the market has been categorized into instruments, reagents and kits, and services.
• Based on the applications, the market has been divided into target identification and validation, primary and secondary screening, toxicology assessment, and others.
• On the basis of the end user, the market has been segregated into pharmaceutical and biotechnology firms, academic and government institutes, contract research organizations, and others.
• The increasing innovation in drug discovery processes is a primary driver of the high-throughput screening market.
• Rising investment in research and development (R&D) efforts and the integration of robotics and automation are reshaping the high-throughput screening market.

Request a sample copy of the report: https://www.imarcgroup.com/high-throughput-screening-market/requestsample

Industry Trends and Drivers:

• Advancements in drug discovery:

The high-throughput screening market is primarily driven by the growing need for efficient drug discovery processes. As pharmaceutical and biotechnology companies work to develop new therapies for complex diseases, high-throughput screening technology allows researchers to rapidly screen large libraries of compounds to identify potential drug candidates. The ability to test thousands or even millions of compounds simultaneously increases the likelihood of finding effective treatments while significantly reducing the time and cost involved in the early stages of drug development. With rising demand for precision medicine and personalized treatments, high-throughput screening provides a powerful tool for identifying targeted therapies, supporting the overall growth of the market.

• Integration of automation and robotics:

The incorporation of automation and robotics in high-throughput screening has revolutionized the process, propelling market expansion. Automation has allowed for faster, more accurate, and reproducible screening processes, reducing the potential for human error and increasing throughput. Moreover, robotic systems and advanced liquid handling technologies streamline the screening workflow, allowing for continuous, around-the-clock operations in laboratories. As laboratories strive to increase efficiency and productivity, the adoption of automated high-throughput screening systems has become more widespread. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) into high-throughput screening platforms enables researchers to analyze data more effectively, improving the accuracy of hit identification and leading to better decision-making during the drug discovery process.

• Increasing investments in pharmaceutical research and development:

Rising investments in pharmaceutical research and development (R&D) are contributing significantly to the growth of the high-throughput screening market. With the pharmaceutical industry under pressure to develop innovative therapies for a range of diseases, companies are allocating significant resources to R&D efforts. Governments, private institutions, and venture capitalists are also increasing their funding to accelerate drug discovery, which is further propelling the demand for high-throughput screening technologies. Moreover, the growing focus on cancer, neurological disorders, and infectious diseases, among others, has increased research activities, increasing the adoption of high-throughput screening platforms in academic and commercial settings. This increased investment in R&D is boosting the pace of innovation and facilitating the expansion of the high-throughput screening market.

High-throughput Screening Market Report Segmentation:

Breakup By Technology:

• Ultra-High-Throughput Screening
• Cell-Based Assays
• Lab-on-a-Chip
• Label-Free Technology

Based on technology, the market has been segregated into ultra-high-throughput screening, cell-based assays, lab-on-a-chip, and label-free technology.

Breakup By Products and Services:

• Instruments
• Reagents and Kits
• Services

On the basis of the products and services, the market has been divided into instruments, reagents and kits, and services.

Breakup By Applications:

• Target Identification and Validation
• Primary and Secondary Screening
• Toxicology Assessment
• Others

Based on the applications, the market has been categorized into target identification and validation, primary and secondary screening, toxicology assessment, and others.

Breakup By End User:

• Pharmaceutical and Biotechnology Firms
• Academic and Government Institutes 
• Contract Research Organizations
• Others

On the basis of the end user, the market has been segmented into pharmaceutical and biotechnology firms, academic and government institutes, contract research organizations, and others.

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Region-wise, the market has been classified into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.

Top High-throughput Screening Market Leaders:

The high-throughput screening market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

• Agilent Technologies Inc.
• Aurora Biomed Inc.
• Axxam S.p.A
• Beckman Coulter Inc. (Danaher Corporation)
• Bio-RAD Laboratories Inc.
• Charles River Laboratories International Inc.
• Corning Incorporated
• Luminex Corporation (DiaSorin)
• Perkinelmer Inc.
• Sygnature Discovery
• Tecan Group Ltd
• Thermo Fisher Scientific 

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.